BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24359967)

  • 1. Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.
    Memon AA; Sundquist J; Zöller B; Wang X; Dahlbäck B; Svensson PJ; Sundquist K
    Thromb Res; 2014 Mar; 133(3):322-6. PubMed ID: 24359967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Expression Level of Apolipoprotein M as a Diagnostic Marker for Primary Venous Thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Elf J; Svensson PJ; Strandberg K; Sundquist J; Memon AA
    Clin Appl Thromb Hemost; 2018 Apr; 24(3):416-422. PubMed ID: 28914078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Svensson PJ; Sundquist J; Memon AA
    Thromb Haemost; 2016 Aug; 116(3):432-41. PubMed ID: 27277397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study.
    Gándara E; Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; Le Gal G; Solymoss S; Crowther M; Carrier M; Langlois N; Kovacs J; Little Ma J; Carson N; Ramsay T; Rodger MA
    Thromb Haemost; 2013 Dec; 110(6):1172-9. PubMed ID: 24067945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.
    Memon AA; Sundquist K; Wang X; Svensson PJ; Sundquist J; Zöller B
    J Thromb Thrombolysis; 2014 Oct; 38(3):348-54. PubMed ID: 24402195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
    Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
    Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
    Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
    Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
    Rodger MA; Le Gal G; Carrier M; Betancourt MT; Kahn SR; Wells PS; Anderson DA; Lacut K; Chagnon I; Solymoss S; Crowther M; Perrier A; White R; Vickars L; Ramsay T; Kovacs MJ
    Thromb Res; 2010 Sep; 126(3):222-6. PubMed ID: 20580413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
    Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
    Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein and the risk of recurrent venous thromboembolism.
    Eichinger S; Pecheniuk NM; Hron G; Deguchi H; Schemper M; Kyrle PA; Griffin JH
    Circulation; 2007 Mar; 115(12):1609-14. PubMed ID: 17372172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid lowering drugs and the risk of recurrent venous thromboembolism.
    Delluc A; Tromeur C; Le Moigne E; Nowak E; Mottier D; Le Gal G; Lacut K
    Thromb Res; 2012 Dec; 130(6):859-63. PubMed ID: 22939687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study.
    Di Minno MN; Dentali F; Lupoli R; Ageno W
    Circulation; 2014 Jan; 129(4):497-503. PubMed ID: 24146249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
    Ljungqvist M; Sonnevi K; Bergendal A; Holmström M; Kieler H; Lärfars G
    Thromb Res; 2014 May; 133(5):762-7. PubMed ID: 24613699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.